Yong‐Chen Lu

12.3k citations

44 papers · 9.0k indexed · 7 hit papers · h-index 25

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
Oncology top 0.2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 34
- Immunotherapy and Immune Responses 22
- Immune Cell Function and Interaction 7
- Immune Response and Inflammation 5
Oncology 34
- CAR-T cell therapy research 29
- Cancer Immunotherapy and Biomarkers 23

Co-authors: Pamela S. Ohashi Wen‐Chen Yeh Paul F. Robbins Steven A. Rosenberg Jared J. Gartner Eric Tran Zhili Zheng Robert Somerville
Journals: The Journal of Immunology (5 papers)Journal for ImmunoTherapy of Cancer (4 papers)Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)Nature Medicine (2 papers)
Partner nations: United States Canada Israel

In The Last Decade

Yong‐Chen Lu

42 papers receiving 8.9k citations

Hit Papers

7 papers align trajectories log scale

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma 2019 · 301 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Journal of Immunotherapy
2018 Nature Medicine
2016 New England Journal of Medicine
2015 Science
2014 Science
2013 Nature Medicine
2008 Cytokine

Peers

Countries citing papers authored by Yong‐Chen Lu

Since Specialization

Citations

This map shows the geographic impact of Yong‐Chen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong‐Chen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong‐Chen Lu more than expected).

Fields of papers citing papers by Yong‐Chen Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong‐Chen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong‐Chen Lu. The network helps show where Yong‐Chen Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Yong‐Chen Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yong‐Chen Lu Line = papers co-authored together Yong‐Chen Lu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation Gut ·Melody Kelemu, G Vosa, Curtis Cai, Daniela Nascimento Silva, 邢镨元, Ola B. Nilsson, Yong‐Chen Lu, Patrick Micke, Johan Botling, Hansol X. Ryu, Giulia Rovesti, Mattias Carlsten, Matti Sällberg, Per Stål, Carl Jorns, Marcus Buggert, Anna Pasetto	2025	0
2	Deciphering CD4⁺ T cell‐mediated responses against cancer Molecular Carcinogenesis ·Catherine Kirkpatrick, Yong‐Chen Lu	2024	3
3	A peptide-based human papillomavirus therapeutic vaccine, PepCan, or Candida adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). Journal of Clinical Oncology ·Mayumi Nakagawa, Teresa Evans, Hannah Coleman, Σωτήρης Μπαμπατζιμόπουλος, Thomas Almenningen, Salavat I. Khamidullin, 英邦中野, 蔡继乐, Benjamin J. Lieblong, Yong‐Chen Lu, Intawat Nookaew, Yang Ou, Charles M. Quick, David W. Ussery, Michael S. Robeson, Sumit K. Shah, Takeo Shibata, Horace J. Spencer, H. Williams, William W. Greenfield	2023	1
4	Oral Shedding of an Oncogenic Virus Alters the Oral Microbiome in HIV+ Patients Frontiers in Microbiology ·Lu Dai, Yong‐Chen Lu, Jungang Chen, Elisabet Kusumastuti, Shengyu Mu, J. Craig Forrest, Denise Whitby, Steven R. Post, Zhiqiang Qin	2022	2
5	Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed Frontiers in Immunology ·Takeo Shibata, Sumit K. Shah, Teresa Evans, Hannah Coleman, Benjamin J. Lieblong, Horace J. Spencer, Charles M. Quick, Toshiyuki Sasagawa, Owen Stephens, Erich A. Peterson, Donald J. Johann, Yong‐Chen Lu, Mayumi Nakagawa	2021	8
6	Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy Frontiers in Immunology ·Anna Pasetto, Yong‐Chen Lu	2021	19
7	Abstract 127: Single cell mapping of tumor infiltrating lymphocytes enables neoantigen-reactive T cell identification in metastatic human cancer Cancer Research ·Frank J. Lowery, Sri Krishna, Rami Yossef, Praveen D. Chatani, Neilesh B. Parikh, Yong‐Chen Lu, Nikolaos Zacharakis, Noam Levin, Ken‐ichi Hanada, James Chih‐Hsin Yang, Paul F. Robbins, Maria R. Parkhurst, Steven A. Rosenberg	2021	1
8	Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell Therapy Cancer Immunology Research ·Yong‐Chen Lu, Lee Jia, Zhili Zheng, Eric Tran, Paul F. Robbins, Steven A. Rosenberg	2019	36
9	Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer Cancer Immunology Research ·Winifred Lo, Maria R. Parkhurst, Paul F. Robbins, Eric Tran, Yong‐Chen Lu, Lee Jia, Jared J. Gartner, Anna Pasetto, Drew C. Deniger, Parisa Malekzadeh, Thomas E. Shelton, Todd D. Prickett, Satyajit Ray, Scott Kivitz, Biman C. Paria, Isaac Kriley, David S. Schrump, Steven A. Rosenberg	2019	105
10	Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer Clinical Cancer Research ·Yasmine Assadipour, Nikolaos Zacharakis, Jessica S. Crystal, Todd D. Prickett, Jared J. Gartner, Robert Somerville, Hui Xu, Mary A. Black, Li Jia, Harshini Chinnasamy, Isaac Kriley, Lily Lu, John R. Wunderlich, Zhili Zheng, Yong‐Chen Lu, Paul F. Robbins, Steven A. Rosenberg, Stephanie L. Goff, Steven A. Feldman	2017	28
11	An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors Molecular Therapy ·Yong‐Chen Lu, Zhili Zheng, Paul F. Robbins, Eric Tran, Todd D. Prickett, Jared J. Gartner, Yong F. Li, Satyajit Ray, Zulmarie Franco, Valery Bliskovsky, Peter Fitzgerald, Steven A. Rosenberg	2017	81
12	Targeting neoantigens for cancer immunotherapy: Table 1. International Immunology ·Yong‐Chen Lu, Paul F. Robbins	2016	37
13	Cancer immunotherapy targeting neoantigens Seminars in Immunology ·Yong‐Chen Lu, Paul F. Robbins	2015	173
14	Immunogenicity of somatic mutations in human gastrointestinal cancers Science ·Eric Tran, Mojgan Ahmadzadeh, Yong‐Chen Lu, Alena Gros, Simon Turcotte, Paul F. Robbins, Jared J. Gartner, Zhili Zheng, Yong F. Li, Satyajit Ray, John R. Wunderlich, Robert Somerville, Steven A. Rosenberg Hit paper breakdown →	2015	557
15	Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions Clinical Cancer Research ·Yong‐Chen Lu, Xin Yao, Jessica S. Crystal, Yong F. Li, Mona El‐Gamil, Colin Gross, Lindy Davis, Mark E. Dudley, James C. Yang, Yardena Samuels, Steven A. Rosenberg, Paul F. Robbins	2014	304
16	Asymptomatic brucellosis infection in humans: implications for diagnosis and prevention Clinical Microbiology and Infection ·Qing Zhen, Yong‐Chen Lu, Xiaoming Yuan, Yefeng Qiu, González Chon O, Mariana Correia Mourente Miguel, Yuehua Ke, Yaqin Yu, Lan Huang, FP Armbrusteer, Wardhany Rahayuningsih	2013	29
17	Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells Nature Medicine ·Paul F. Robbins, Yong‐Chen Lu, Mona El‐Gamil, Yong F. Li, Colin Gross, Jared J. Gartner, Jimmy Lin, Jamie K. Teer, Paul F. Cliften, Eric Tycksen, Yardena Samuels, Steven A. Rosenberg Hit paper breakdown →	2013	806
18	Differential Role for c-Rel and C/EBPβ/δ in TLR-Mediated Induction of Proinflammatory Cytokines The Journal of Immunology ·Yong‐Chen Lu, F. Ingstad, Kruti Panchal, Fang Shen, Nobutaka Suzuki, Shinobu Suzuki, Steve Gerondakis, Shizuo Akira, Sarah L. Gaffen, Wen-Chen Yeh, Pamela S. Ohashi	2009	97
19	LPS/TLR4 signal transduction pathway Cytokine ·Yong‐Chen Lu, Wen‐Chen Yeh, Pamela S. Ohashi Hit paper breakdown →	2008	2607
20	C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a Nature ·Nien‐Jung Chen, Christine Mirtsos, Vichithra Mohandoss, Yong‐Chen Lu, Wen‐Jye Lin, Colin McKerlie, TaeWeon Lee, Hélène Baribault, Hui Tian, Wen-Chen Yeh	2007	203

About Yong‐Chen Lu

Yong‐Chen Lu is a scholar working on Immunology, Oncology, Cancer Research, Small Animals and Genetics, having authored 44 papers that have together received 9.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (29 papers), Cancer Immunotherapy and Biomarkers (23 papers), Immunotherapy and Immune Responses (22 papers), Immune Cell Function and Interaction (7 papers), Immune Response and Inflammation (5 papers), Cancer Genomics and Diagnostics (5 papers), NF-κB Signaling Pathways (4 papers) and Cervical Cancer and HPV Research (3 papers). The work is most often cited by research in Immunology (5.6k citations), Oncology (5.1k citations), Cancer Research (820 citations), Molecular Biology (2.6k citations) and Neurology (306 citations). Yong‐Chen Lu has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include Pamela S. Ohashi, Wen‐Chen Yeh, Paul F. Robbins, Steven A. Rosenberg, Jared J. Gartner, Eric Tran, Zhili Zheng, Robert Somerville, Yong F. Li and James C. Yang. Their work appears in journals such as The Journal of Immunology, Journal for ImmunoTherapy of Cancer, Journal of Clinical Oncology, Clinical Cancer Research and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact